Analysis of the genotype-related blood pressure response to APOE (Figure 14), NOS3 (Figure 15), ACE (Figure 16), and AGT variants (Figure 17) revealed that specific polymorphisms in these genes differentially influence the hypotensive effect of Enalapril in AD patients. This evidence concerns the gene ACE and Alzheimer disease.